# PLENVU
> **NDA209381** · New Drug Application · Sponsor: SALIX · Approved 2018-05-04
## Drug
- **FDA Application Number:** NDA209381
- **Application type:** New Drug Application
- **Brand name:** PLENVU
- **Generic name:** POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE
- **Active ingredients:** ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SALIX
- **Manufacturer:** Salix Pharmaceuticals, Inc
- **First approval:** 2018-05-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209381)
---
*MORVS · CC0 1.0*